Clinical use and standard of care: what “maturity” means after launch
After launch, maturity is about sustained performance, workflow integration, and evidence that holds up over time across contexts.
Stakeholder value: how to prove value to clinicians, managers, payers
Adoption requires different proof packages for different stakeholders. Value is not one metric, but a set of decision drivers.
Real-world evidence: when retrospective data is enough and when it is not
Retrospective data can be the fastest way to build credibility, but it is not always sufficient. The right choice depends on the decision you need to unlock.
How to write a TRL story that matches your workplan and budget
strong TRL story is a project logic: starting point, proof steps, outputs, and end point. It must match time, methods, and budget.
EU funding readiness: what reviewers look for in your pathway to impact
Reviewers fund credible pathways, not only good ideas. The strongest proposals connect TRL, evidence, workplan, and impact logically.
From “interest” to “purchase”: what changes in your proof as you scale
Early interest is easy. Purchase requires proof that reduces operational and financial risk, with clear implementation and impact evidence.
Clinical value is not UX. What stakeholders call “benefit”
Good UX helps adoption, but clinical value is measured by outcomes, decisions, and workflow impact. Confusing the two blocks scale.
Evidence strategy by TRL: what to prove at each stage
Evidence is not one big study at the end. It is a staged plan where each TRL step has a proof goal, method, and decision outcome.
The multi-dimensional trap: you can be TRL6 technically and TRL2 clinically
Digital health maturity is not one number. Teams often overbuild tech while under-proving clinical value, which blocks funding and scale.
Proof-of-Value: the missing step between pilots and adoption
Many pilots succeed yet never scale because they prove functionality, not value. Proof-of-Value connects evidence to adoption decisions.
TRL is self-reported. Here is how to prove it credibly
TRL claims are often optimistic. Credibility comes from linking each TRL statement to concrete proof and decision-grade evidence.
TRL in digital health: why maturity is your best funding and go-to-market tool
TRL is not paperwork. It is the shared language that reduces risk for funders and buyers by making your next proof step clear.
